https://www.selleckchem.com/pr....oducts/bismuth-subni
LOUE patients had on average a 2.3% (adjusted), 7.4% (unadjusted) increased FHS-CVD score. Our findings highlight LOUE as pharmacosensitive and left temporal predominant. Given the higher prevalence of vascular risk factors, investigations are needed to study their role in pathophysiology. Physicians caring for patients with LOUE should evaluate for vascular risk factors and investigate the presence of hippocampal atrophy. Physicians caring for patients with LOUE should evaluate for vascular risk factors and investigate the p
Like
Comment
Share
